|
ORLANDO, MD, May 21, 2008—Men aged 75-80 with prostate-specific antigen (PSA) levels less than 3 ng/ml may be able to discontinue their regular prostate cancer screenings, according to new research presented today during the Annual Scientific Meeting of the American Urological Association (AUA). Johns Hopkins University researchers found that men in this age group who had a PSA level of 3 ng/ml or above had an increasing probability of death from prostate cancer in their remaining life, while men with lower PSA levels did not.
AUA2008: Regular Prostate-Specific Antigen Screening May be Discontinued in Men 75-80 |
|
|
ORLANDO, FL, May 21, 2008—Men with greater access to prostate cancer screenings and treatment have better outcomes from the disease, a new study shows. Urologist population density was directly related to increased numbers of screening programs and decreased mortality rates from the disease. Today, researchers from the University of Alabama, Birmingham, presented data from the Behavioral Risk Factor Surveillance System of the Centers for Disease Control and Prevention (CDC) confirming the relationship.
AUA 2008: ACCESS TO UROLOGISTS AND PROSTATE CANCER SCREENINGS LEAD |
|
|
ORLANDO, FL, May 21, 2008 – Managing your cholesterol may also help you manage your prostate- specific antigen (PSA) level. Data presented today at the 103rd Annual Scientific Meeting of the American Urological Association explored the relationship between low-density lipoprotein (LDL) cholesterol and PSA prior to beginning statin therapy.
AUA 2008: LOW CHOLESTEROL LEADS TO LOWER PSA |
|
|
ORLANDO, FL, May 20, 2008 – Transplantation of muscle-derived stem cells may provide a safe and effective treatment for patients suffering from urinary incontinence following a surgical procedure. Two studies presented today at the 103rd Annual Scientific Meeting of the American Urological Association (AUA), show that patients with incontinence resulting from iatrogenic sphincter damage may benefit from this therapy. Researchers from Germany and Austria presented findings from two studies to reporters in special press conferences on May 20, 2008 at 1:00 p.m. and 1:30 p.m.
AUA 2008: URIC ACID STONES MAY INDICATE ARTERIOSCLEROTIC DISEASES |
|
|
ORLANDO, FL, May 20, 2008 – Transplantation of muscle-derived stem cells may provide a safe and effective treatment for patients suffering from urinary incontinence following a surgical procedure. Two studies presented today at the 103rd Annual Scientific Meeting of the American Urological Association (AUA), show that patients with incontinence resulting from iatrogenic sphincter damage may benefit from this therapy. Researchers from Germany and Austria presented findings from two studies to reporters in special press conferences on May 20, 2008 at 1:00 p.m. and 1:30 p.m
AUA 2008: MUSCLE-DERIVED STEM CELLS PROVE EFFECTIVE IN REPARING SPHINCTER DAMAGE TO RESTORE CONTINEN |
|
|
|
<< Start < Prev 1 2 Next > End >>
|
| Results 1 - 9 of 11 |
All material
provided on the pages located in the Vibrance Network domains are provided for educational purposes only and are not intended to be a substitute for professional medical advice. Always consult your own physician
regarding the applicability of any information on this site with respect to your symptoms or medical condition.
Using this site assumes you have read and agreed to the disclaimer. © Copyright 2008. Vibrance Associates,
LLC.
All Rights
Reserved.